1. High-throughput screening and validation of antibodies against synaptic proteins to explore opioid signaling dynamics
- Author
-
Catherine Woods, Nikita A. Trimbake, Erin N. Bobeck, Achla Gupta, Christine Tumanut, Xiaomin Fan, Deborah Schechtman, Akila Ram, Lakshmi A. Devi, Mariana Lemos Duarte, and Ivone Gomes
- Subjects
0301 basic medicine ,Male ,Time Factors ,QH301-705.5 ,High-throughput screening ,Receptors, Opioid, mu ,Medicine (miscellaneous) ,Computational biology ,Yeast display ,General Biochemistry, Genetics and Molecular Biology ,Article ,Antibodies ,Immunological techniques ,03 medical and health sciences ,0302 clinical medicine ,Genome editing ,Antibody Specificity ,Cell Line, Tumor ,Animals ,Humans ,Biology (General) ,Phosphorylation ,Receptor ,Protein Kinase C ,Microscopy ,biology ,Morphine ,Immunochemistry ,HEK 293 cells ,Cellular neuroscience ,High-Throughput Screening Assays ,Analgesics, Opioid ,Enzyme Activation ,Fentanyl ,Mice, Inbred C57BL ,030104 developmental biology ,HEK293 Cells ,Synapses ,biology.protein ,Rabbits ,Antibody ,Signal transduction ,General Agricultural and Biological Sciences ,030217 neurology & neurosurgery ,ÓPIO ,Signal Transduction - Abstract
Antibodies represent powerful tools to examine signal transduction pathways. Here, we present a strategy integrating multiple state-of-the-art methods to produce, validate, and utilize antibodies. Focusing on understudied synaptic proteins, we generated 137 recombinant antibodies. We used yeast display antibody libraries from the B cells of immunized rabbits, followed by FACS sorting under stringent conditions to identify high affinity antibodies. The antibodies were validated by high-throughput functional screening, and genome editing. Next, we explored the temporal dynamics of signaling in single cells. A subset of antibodies targeting opioid receptors were used to examine the effect of treatment with opiates that have played central roles in the worsening of the ‘opioid epidemic.’ We show that morphine and fentanyl exhibit differential temporal dynamics of receptor phosphorylation. In summary, high-throughput approaches can lead to the identification of antibody-based tools required for an in-depth understanding of the temporal dynamics of opioid signaling., Lemos Duarte et al. describe a strategy to produce, validate, and utilize highly-specific recombinant antibodies. As a proof of principle, they demonstrate development and validation of a panel of antibodies against proteins relevant to signaling by opiates. Their antibody-based tool can be useful in understanding the spatio-temporal dynamics of opioid signaling.
- Published
- 2021